| Fri, 15 Jan 2021 14:48:56: | JPM: Established relationships were key to pandemic drug launches, Incyte CEO says
|
| Fri, 15 Jan 2021 13:04:34: | Fujifilm continues CMDO expansion spree with $76M in funding for new Boston site
|
| Fri, 15 Jan 2021 10:21:07: | Fierce Pharma Asia—BeiGene-Novartis PD-1 deal; Sinovac vaccine; Celltrion antibody COVID-19 data
|
| Thu, 14 Jan 2021 16:51:15: | JPM sound bites, vol. 2: Mushy brains, chewing gum and walking, and that good old San Francisco weather
|
| Thu, 14 Jan 2021 16:28:13: | Regeneron inks big new coronavirus antibody supply deal worth up to $2.6B
|
| Thu, 14 Jan 2021 15:56:21: | Woodcock to step up to interim FDA chief as she and Sharfstein are vetted for permanent job: reports
|
| Thu, 14 Jan 2021 14:39:33: | He's in! 'Shark Tank' star Cuban launches generics maker promising 'radically' low-cost drugs
|
| Thu, 14 Jan 2021 13:20:47: | CDMO Catalent tackles Warp Speed juggling act with new $50M Bloomington line, Acorda plant buyout
|
| Thu, 14 Jan 2021 12:26:24: | Moderna hitches a ride with Uber to boost vaccine confidence—and, of course, drive access
|
| Wed, 13 Jan 2021 19:12:20: | JPM: Jazz eyes a 'dramatic' shift to new-drug revenue by 2022, CEO says
|
| Wed, 13 Jan 2021 16:21:32: | JPM: How did Pfizer up its COVID-19 vaccine capacity? 'Out of the box manufacturing,' CEO says
|
| Wed, 13 Jan 2021 16:18:09: | What do Novartis deal, PD-1 competition in China mean for tislelizumab? Here's what BeiGene's CEO has to say
|
| Wed, 13 Jan 2021 15:55:39: | Pharmas pause political contributions in wake of Capitol riots, GOP anti-certification votes
|
| Wed, 13 Jan 2021 14:52:17: | JPM, Day 3: Fujifilm's bio CDMO growth, Catalent's 'coveted' COVID-19 assets, Teva's post-cutback aims—and more
|
| Wed, 13 Jan 2021 14:26:14: | Johnson & Johnson's COVID-19 vaccine production lags goals as data readout nears: NYT
|
| Wed, 13 Jan 2021 12:50:55: | Meet EUROAPI: Sanofi christens to-be-spun-off drug ingredients business, taps CEO
|
| Tue, 12 Jan 2021 20:51:49: | JPM: Sanofi's new chief digital officer steps up ambitions in marketing, research and even e-commerce
|
| Tue, 12 Jan 2021 17:38:49: | COVID-19 in the ER? Level Ex uses J&J grant to simulate infections in medical education video games
|
| Tue, 12 Jan 2021 15:40:28: | JPM: Lilly, Moderna, insitro CEOs say pandemic forced R&D, marketing and ops changes worth keeping
|
| Tue, 12 Jan 2021 13:51:36: | Novavax taps Baxter for commercial production as COVID-19 vaccine nears finish line
|
| Tue, 12 Jan 2021 11:35:41: | Novartis lays out $650M-plus for BeiGene's tislelizumab as its own PD-1 fails to impress
|
| Mon, 11 Jan 2021 22:55:41: | JPM: 'Very soon,' says Johnson & Johnson CEO as world waits for its COVID-19 vaccine data
|
| Mon, 11 Jan 2021 21:15:23: | W2O Group rolls up 2 new data agency buys into one health tech business
|
| Mon, 11 Jan 2021 18:59:34: | Fierce JPM Week: Will the first COVID-19 vaccines deter future launches? Not at all, experts say
|
| Mon, 11 Jan 2021 18:54:18: | Fierce JPM Week: Genentech CEO says partnerships, speedier trials among pandemic's 'silver linings'
|
